Meeting with Boriša Falatar (Cabinet of Commissioner Hadja Lahbib)

4 Sept 2025 · HIV prevention

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

8 Jul 2025 · Review of the EU General Pharmaceutical Legislation

Meeting with Cecile Billaux (Head of Unit Directorate-General for International Partnerships)

1 Jul 2025 · Gilead’s long-acting HIV prevention drug: LENACAPAVIR – access in Africa

Meeting with Michael McGrath (Commissioner)

20 Jun 2025 · Exchange of views on issues relating to competitiveness and corporate sustainability

Meeting with Dolors Montserrat (Member of the European Parliament)

26 May 2025 · Cancer treatments and HIV vaccines

Meeting with Vincenzo Matano (Cabinet of Executive Vice-President Raffaele Fitto)

27 Mar 2025 · General Exchange on the Company’s Activities

Meeting with Olivier Chastel (Member of the European Parliament)

24 Oct 2024 · Politique de santé de l Union européenne

Meeting with Thomas Bajada (Member of the European Parliament)

23 Oct 2024 · Meeting on HIV policies

Meeting with Nicolás González Casares (Member of the European Parliament)

22 Oct 2024 · HIV

Meeting with Tomislav Sokol (Member of the European Parliament) and International Diabetes Federation European Region

22 Oct 2024 · Health policy

Meeting with Dolors Montserrat (Member of the European Parliament)

10 Oct 2024 · Prevention of infectious diseases

Meeting with Nicolás González Casares (Member of the European Parliament)

1 Oct 2024 · HIV

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

19 Mar 2024 · prevention and raising awareness on combating HIV

Meeting with Frédérique Ries (Member of the European Parliament)

6 Feb 2024 · Ending the HIV/AIDS epidemic

Meeting with Stella Kyriakides (Commissioner) and 1 other attendee

19 Jan 2024 · Meeting with Spanish Women’s Coalition on Triple Negative Breast Cancer on Europe’s Beating Cancer Plan and EU policies on cancer

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

15 Dec 2023 · Directive on Medicinal products for human use

Meeting with Geoffroy Didier (Member of the European Parliament, Shadow rapporteur)

29 Nov 2023 · Compulsory licensing

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

28 Nov 2023 · cancer

Meeting with Dolors Montserrat (Member of the European Parliament)

7 Nov 2023 · Revision of the pharmaceutical legislation

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

7 Nov 2023 · cancer

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and EUROPEAN ORGANISATION FOR RARE DISEASES

5 Oct 2023 · Directive on Medicinal products for human use

Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament)

21 Sept 2023 · Pharmaceutical review

Meeting with Nicolás González Casares (Member of the European Parliament)

21 Sept 2023 · Reform of the EU pharmaceutical legislation

Meeting with Patrizia Toia (Member of the European Parliament)

21 Sept 2023 · Pharmaceutical policies (meeting held by the APA responsible)

Meeting with Maria da Graça Carvalho (Member of the European Parliament)

20 Sept 2023 · EU healthcare policy discussions and legislation

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Affordable Medicines Europe

12 Jul 2023 · Directive on Medicinal products for human use

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

29 Mar 2023 · Advanced therapies

Meeting with Patricia Reilly (Cabinet of Commissioner Mairead Mcguinness)

22 Mar 2023 · Discussed Gilead’s manufacturing operations in Ireland and globally. Gilead outlined their concerns with the soon to be published EU Pharmaceutical strategy, with particular emphasis on unmet medical needs, regulatory data protection and innovation

Meeting with Frédérique Ries (Member of the European Parliament)

22 Mar 2023 · Révision de la législation pharmaceutique européenne

Meeting with Carlo Fidanza (Member of the European Parliament)

22 Mar 2023 · Focus on IMCO files

Meeting with Sara Cerdas (Member of the European Parliament)

8 Feb 2023 · Consent requirements for HIV and viral hepatitis testing in the EU

Meeting with Frédérique Ries (Member of the European Parliament)

7 Feb 2023 · Visite de courtoisie

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

27 Jan 2023 · Lessons learned on impact of COVID-19 pandemic

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

26 Oct 2022 · Advanced therapies

Meeting with Stella Kyriakides (Commissioner)

11 Jun 2021 · Exchange of views on joint procurement and scientific assessment of Remdesivir

Meeting with Stella Kyriakides (Commissioner)

7 Dec 2020 · Exchange of views, update on Remdesivir

Meeting with Stella Kyriakides (Commissioner)

16 Oct 2020 · Exchange of views - update on Remdesivir

Meeting with Stella Kyriakides (Commissioner)

9 Sept 2020 · Discussions/update on Remdesivir

Meeting with Stella Kyriakides (Commissioner)

6 Jul 2020 · VC meeting: Exchange of views on the forthcoming Pharmaceutical Strategy

Meeting with Stella Kyriakides (Commissioner)

2 Jun 2020 · Update on remdesivir

Meeting with Stella Kyriakides (Commissioner)

6 May 2020 · VC meeting on remdesivir as a developmental medicine, the clinical trial programme, actions taken in respect of making remdesivir available via a compassionate use, Member States' needs and distribution should it receive market authorisation

Meeting with Stella Kyriakides (Commissioner)

7 Apr 2020 · Discussion on medicines (potential treatments, production, clinical trials, access to results)

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis)

25 Sept 2017 · Hepatitis B and C, HIV

Meeting with Valdis Dombrovskis (Vice-President) and 9 other attendees

19 Jun 2017 · economic situation within the EU, investment climate, deepening of the EMU, social dimension of the European project, financial regulations and markets